The largest database of trusted experimental protocols

Amphotericin b

Sourced in United States

Amphotericin B is an antifungal agent that is commonly used in cell culture applications. It is effective against a broad spectrum of fungal species and is often used to prevent fungal contamination in cell culture media.

Automatically generated - may contain errors

13 protocols using amphotericin b

1

Ablating Mycobiome in Murine Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
To ablate the mycobiome in mice, animals were administered Amphotericin B (1mg/ml; MP Biomedicals, Santa Ana, CA) by oral gavage daily for five consecutive days in addition to adding Amphotericin B (0.5μg/ml) to mouse drinking water for the duration of the experiment10 (link). Controls were gavaged with PBS. Orthotopic PDA tumor cells were administered or pancreatitis was initiated 3 weeks after commencing treatment with Amphotericin B. Alternatively, mice were treated with Fluconazole (0.5mg/ml; MP Biomedicals) for 3 weeks prior to tumor implantation using the same regimen11 (link). For species-specific repopulation experiments, M. globosa (MYA-4612, 1×108 CFU/ml), S. cerevisiae (7752, 1×108 CFU/ml), C. tropicalis (MYA-3404, 1×108 CFU/ml; all ATCC Manassas, VA), Candida sp. (clinical isolate; 1×108 CFU/ml) or Aspergillus sp. (clinical isolate; 1×106 CFU/ml) were used to orally gavage mice following fungal ablation with Amphotericin B. Recipient mice were administered orthotopic PDA cells 7 days after repopulation. To assess fungal translocation to the pancreas, 108 CFU of GFP-labeled Saccharomyces cerevisiae (ATCC MYA-2011) were introduced via oral gavage, and pancreatic samples were examined at 30 minutes by flow cytometry. All experiments were approved and in compliance with the New York University School of Medicine Institutional Animal Care and Use Committee (IACUC).
+ Open protocol
+ Expand
2

Preparation of Lung Fibroblasts for Organoid Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mlg mouse lung fibroblasts ([MLg2908, CCL206], ATCC, Wesel, Germany) were maintained in DMEM/F12 medium (Life technologies, Carlsbad, USA) supplemented with 10% fetal bovine serum (FBS, PAA Laboratories, Pasching, Austria), penicillin/streptomycin (100 U/ml), glutamine (1%, Life Technologies #35050–061) and Amphotericin B (1×, Gibco). MRC5 human lung fibroblasts (ATCC #CCL-171) were maintained in F12 medium supplemented with 10% FBS, penicillin/streptomycin (100 U/ml), glutamine (1%) and Amphotericin B (1×). Cells were maintained at 37 °C in a humidified incubator with 5% CO2. Prior to organoid culture, Mlg or MRC5 cells at 90% confluence were proliferation-inactivated in medium containing mitomycin C (10 μg/ml, Sigma #M4287) for 2 h, followed by 3 washes in warm PBS (Life technologies) and trypsinization.
+ Open protocol
+ Expand
3

Fibroblast Culture and Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lung fibroblasts MRC5 (CCL-171; ATCC, Wesel, Germany) were cultured in Ham’s F12 medium (Life technologies, Carlsbad, United States) supplemented with 10% (v/v) fetal bovine serum (FBS, PAA Laboratories, Pasching, Austria), 2 mM l-glutamine (Life Technologies #35050–061), 100 U/mL penicillin/streptomycin, and 1% amphotericin B (1x, Gibco). CCL-206 mouse lung fibroblasts ([MLg2908, CCL206], ATCC, Wesel, Germany) were cultured in DMEM/F12 medium supplemented with 10% FBS, penicillin/streptomycin (100 U/mL), glutamine (1%) and amphotericin B. Cells were incubated at 37°C, 5% CO2 humidified environment. MRC5 or CCL206 fibroblasts were starved once grown to 80% confluence in the 6-well culture plates. The starvation medium contains the same components as culture medium described above, but with only 0.5% FBS. After 24 h starvation, cells were then incubated with either vehicle, TGF-β1 and/or investigational compounds (Table 1) in serum deprivation medium for 48 h. MRC5 fibroblasts were collected for gene expression analysis. CCL206 fibroblasts were washed three times with warm PBS and proliferation-inactivated by incubation in mitomycin C (10 μg/ml, Sigma #M4287) for 2 h, followed by three washes in warm PBS and trypsinization prior to mixing with epithelial cells, as described previously (Ng-Blichfeldt et al., 2018 (link); Ng-Blichfeldt et al., 2019 (link)).
+ Open protocol
+ Expand
4

Culturing Mammary Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 cells were obtained from American Type Culture Collection (ATCC) and maintained in DMEM (Genesee Scientific) supplemented with 10% FBS (Gemini Bio-Products), 1% non-essential amino acids (Gemini Bio-Products), and 1% antibiotic/antimycotic solution (Gemini Bio-Products) containing 100 IU/ml penicillin, 100 µg/ml streptomycin and 25 µg/ml amphotericin B. Primary human mammary epithelial cells (HMECs) were obtained from ATCC, and cultured in Mammary Epithelial Cell Basal Medium (ATCC) supplemented with a Mammary Epithelial Cell Growth kit (ATCC) containing 5 µg/ml hH-insulin, 6 mM L-glutamine, 0.5 µM epinephrine, 5 µg/ml apo-transferrin, 5 ng/ml rH-TGF-α, 0.4% ExtractP and 100 ng/ml hydrocortisone hemisuccinate. MCF-10A cells were obtained from ATCC and cultured in DMEM/Ham's F12 media supplemented with 5% Equine Serum (Gemini Bio-Products), 20 ng/ml epidermal growth factor (Sigma-Aldrich; Merck KGaA), 10 µg/ml insulin (Sigma-Aldrich; Merck KGaA), 0.5 mg/ml hydrocortisone (Sigma-Aldrich; Merck KGaA), 100 ng/ml cholera toxin (Sigma-Aldrich; Merck KGaA) and 1% antibiotic/antimycotic solution. All cells were maintained in 5% CO2 at 37°C in a humidified incubator.
+ Open protocol
+ Expand
5

Maintenance of Human Aortic SMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human vascular aortic smooth muscle cells (HAoSMCs) (American Type Culture Collection, ATCC, Manassas, VA, USA) were maintained in a humidified atmosphere at 37℃ with 5% CO2, and cultured in VSMC basal medium supplemented with 5 ng/mL rhFGF-basic, 5 µg/mL rhInsulin, 5 ng/mL rhEGF, 10 mM L-glutamine, 50 µg/mL ascorbic acid, 5% fetal bovine serum, 10 µg/mL gentamicin, 10 Units/mL penicillin, 10 µg/mL streptomycin, 0.28 µg/mL amphotericin B, and 33 µM phenol red (ATCC, Manassas, VA, USA).
+ Open protocol
+ Expand
6

Ablating Mycobiome in Murine Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
To ablate the mycobiome in mice, animals were administered Amphotericin B (1mg/ml; MP Biomedicals, Santa Ana, CA) by oral gavage daily for five consecutive days in addition to adding Amphotericin B (0.5μg/ml) to mouse drinking water for the duration of the experiment10 (link). Controls were gavaged with PBS. Orthotopic PDA tumor cells were administered or pancreatitis was initiated 3 weeks after commencing treatment with Amphotericin B. Alternatively, mice were treated with Fluconazole (0.5mg/ml; MP Biomedicals) for 3 weeks prior to tumor implantation using the same regimen11 (link). For species-specific repopulation experiments, M. globosa (MYA-4612, 1×108 CFU/ml), S. cerevisiae (7752, 1×108 CFU/ml), C. tropicalis (MYA-3404, 1×108 CFU/ml; all ATCC Manassas, VA), Candida sp. (clinical isolate; 1×108 CFU/ml) or Aspergillus sp. (clinical isolate; 1×106 CFU/ml) were used to orally gavage mice following fungal ablation with Amphotericin B. Recipient mice were administered orthotopic PDA cells 7 days after repopulation. To assess fungal translocation to the pancreas, 108 CFU of GFP-labeled Saccharomyces cerevisiae (ATCC MYA-2011) were introduced via oral gavage, and pancreatic samples were examined at 30 minutes by flow cytometry. All experiments were approved and in compliance with the New York University School of Medicine Institutional Animal Care and Use Committee (IACUC).
+ Open protocol
+ Expand
7

Hyperglycemic hASMC Culture and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human aortic smooth muscle cells (hASMCs) (ATCC PCS-100-012, American Type Culture Collection, ATCC, Manassas, VA, USA) were maintained in a humidified atmosphere of 37 °C, with 5% CO2 in VSMC basal medium (without glucose and phenol red) (ATCC® PCS-100-030™) supplemented with recombinant human basic fibroblast growth factor (5 ng/mL), rhInsulin (5 µg/mL), recombinant human epidermal growth factor (5 ng/mL), L-glutamine (10 mM), ascorbic acid (50 µg/mL), fetal bovine serum (5%), gentamicin (10 µg/mL), penicillin (10 Units/mL), streptomycin (10 µg/mL), amphotericin B (0.28 µg/mL), and phenol red (33 µM) (ATCC). To induce clinically hyperglycemic condition, we stimulated the cells with 25 mM (450 mg/dL) of glucose. Based on our previous study for cell viability [27 (link)], we used 1 and 10 μg/mL concentration of C. turczaninowii extract in this study.
+ Open protocol
+ Expand
8

Culturing Primary Keratinocytes and HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary NHEK cells from neonatal foreskin (PCS-200-010) were purchased from American Type Culture Collection (ATCC, Manassas, VA). The NHEK cells were cultured in the Dermal Cell Basal Medium (ATCC, Manassas, VA) supplemented with the Keratinocyte Growth Kit (ATCC, Manassas, VA) and antibiotics (10 µg/mL of gentamicin, 0.25 µg/mL of amphotericin B, 10 U/mL of penicillin, 10 µg/mL of streptomycin, 25 ng/mL of amphotericin B; ATCC, Manassas, VA) according to the manufacturer's instructions. Immortalized nontumorigenic human keratinocytes, HaCaT cells [15] (link), were kindly provided by Dr. Norbert E. Fusenig (German Cancer Research Center, Heidelberg, Germany). The HaCaT cells were cultured in Dulbecco's modified Eagle's medium (Gibco BRL, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, Laboratories Inc., Logan, UT) and antibiotics (100 U/mL of penicillin, 100 µg/mL of streptomycin, and 2 mM L-glutamine; Gibco BRL, Grand Island, NY). Both the NHEK and HaCaT cells were incubated at 37°C in humidified air containing 5% CO2.
+ Open protocol
+ Expand
9

Kidney Proximal Tubule Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human kidney cortex proximal tubule epithelial cells (HK-2, ATCC CRL-2190, ATCC, United Kingdom) were cultured according to the instructions from the manufacturer in keratinocyte serum-free medium, with added bovine pituitary extract (0.05 mg/mL) and epidermal growth factor (5 ng/mL) (all from Invitrogen, United Kingdom). Human primary renal proximal tubule epithelial cells (RPTEC, ATCC PCS-400-010, ATCC) were cultured according to the instructions from the manufacturer. RPTE cells were grown in renal epithelial cell basal media, supplemented with renal epithelial cells growth kit components and antimicrobials: gentamicin (10 μg/mL), amphotericin B (0.275 μg/mL), penicillin (10 units/mL) and streptomycin (10 μg/mL) (all from ATCC). Cell cultures were incubated at 37 °C in the presence of 5% CO2. When cells reached 80–90% confluence, heme (0.5–30 μM, from a freshly prepared 10 mM stock solution), or a mixture of ammonium iron(III) sulfate dodecahydrate, hydrogen peroxide, and ascorbic acid (generating hydroxyl radicals via the Fenton reaction), with or without addition of either Hp (10 μM) or rA1M (10 or 12 μM) or rA1M only, was added, and cells were incubated for up to 24 h. For details on exposure concentrations and time, see the respective figure.
+ Open protocol
+ Expand
10

Hematological Cancer Cell Line Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The panel of hematological cancer cell lines used in this study consisted of BJAB (Burkitt’s Lymphoma), CCRF-CEM (Acute Lymphoblastic Leukemia, ATCC: 62848170), HL-60 (Acute Myelocytic Leukemia, ATCC: 62690063), Jurkat (Acute Lymphocytic Leukemia, ATCC: 62729601), Nalm-6 (Acute Lymphoblastic Leukemia) and Ramos (Burkitt’s Lymphoma, ATCC: 62927031). Five of the cell lines were cultured in RPMI-1640 medium (Corning 10–040-CV) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Atlanta Biologicals Cat No. S11150) and a mixture of 25 μg/ml amphotericin B, 1000 U/ml penicillin, and 1000 μg/ ml streptomycin (Quality Biological 120–096–711). The HL-60 cells were supplemented with 20% FBS in RPMI-1640 medium and the antibiotics mentioned above. The non-cancerous cell lines used were Hs27 (human foreskin fibro-blast, ATCC: 3681588) cultured in DMEM medium supplemented with 10% heat-inactivated FBS and a mixture of 25 μg/ml amphotericin B, 1000 U/ml penicillin and 1000 μg/ml streptomycin, and MCF-10A (human breast epithelium, ATCC: CRL-10317) cultured in DMEM/F12 medium supplemented with FBS and antibiotics as mentioned above, as well as 20 ng/ml epidermal growth factor, 0.5 μg/ ml hydrocortisone (Sigma-Aldrich, H0888) and 10 μg/ ml insulin (Sigma-Aldrich, I1882). All cells were incubated at 37 °C in a humidified atmosphere containing 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!